Thoracic, abdominal, or pelvic tumors
Conditions
Interventions
experimental group:Radioactive particle implantation
Sponsors
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Age >=18 years old, no gender limitation; 2) Patients who relapsed after surgery or external radiotherapy, or refused surgery or external radiotherapy; 3) Patients with thoracic, abdominal, or pelvic tumors who have indications for radioactive particle implantation as assessed by the investigator; 4) Those who signed the informed consent form and volunteered to participate in this clinical trial; 5) Be able to understand the trial and cooperate with the trial procedures, and be able to follow up as required.
Exclusion criteria
Exclusion criteria: 1) Contraindications of radioactive particle implantation surgery a) Patients with severe bleeding tendency, platelet count 18s, prothrombin activity < 40%); b) Rupture of the tumor; c) Severe diabetes; d) No appropriate puncture path as assessed by the investigator; e) The expected planned target dose does not meet the requirements of the prescription dose design; 2) Patients with severe liver and kidney function impairment who could not tolerate surgery as assessed by the investigators; 3) Women who were pregnant, lactating, or planned to have children during the trial; 4) Patients with addiction to drugs, alcohol, etc; 5) Suffering from mental illness, no self-control, unable to express clearly; 6) Participants who had participated in clinical trials of other drugs, biologics, or medical devices before screening and did not meet the time limit for the primary end point; 7) Other conditions that the investigator considers inappropriate for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of puncture;Incidence of surgical complications;Incidence of device defects;Incidence of adverse events and serious adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of puncture adjustments;Duration of surgery;Device performance evaluation; | — |
Countries
China
Contacts
Public ContactZhiyuan Wu
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Outcome results
None listed